Published in Can J Gastroenterol on September 01, 2013
Weekend vs. Weekday Admissions for Cholangitis Requiring an ERCP: Comparison of Outcomes in a National Cohort. Am J Gastroenterol (2016) 0.75
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Guidelines on the management of common bile duct stones (CBDS). Gut (2008) 3.58
Trends in the utilization of endoscopic retrograde cholangiopancreatography (ERCP) in the United States. Am J Gastroenterol (2007) 2.52
Choledochal cyst disease. A changing pattern of presentation. Ann Surg (1994) 2.33
Acute cholangitis. Ann Surg (1980) 2.24
Primary intrahepatic stones. Am J Gastroenterol (1995) 1.77
Morbidity and mortality of colorectal carcinoma surgery differs by insurance status. Cancer (2004) 1.64
Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer (2007) 1.61
Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma. J Gastrointest Surg (2004) 1.56
Palliative percutaneous drainage in malignant biliary obstruction. Part 2: Mechanisms and postprocedure management. J Support Oncol (2006) 1.55
Laparoscopic cholecystectomy and common bile duct stones. The utility of planned perioperative endoscopic retrograde cholangiography and sphincterotomy: experience with 63 patients. Ann Surg (1993) 1.37
Results of the Tokyo Consensus Meeting Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.32
Prevalence of gallstone disease in Hispanic populations in the United States. Gastroenterology (1989) 1.17
Percutaneous transhepatic cholecystostomy for choledocholithiasis with acute cholangitis in high-risk patients. Hepatogastroenterology (2012) 0.80
Duodenoscopic sphincterotomy for common bile duct stones in patients with gallbladder in situ. Int Surg (1991) 0.79
Duodenoscopic sphincterotomy for acute suppurative cholangitis. J Gastroenterol Hepatol (1991) 0.78
Decreasing hospitalization and in-hospital mortality related to cholangitis in the United States. J Clin Gastroenterol (2011) 0.78
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87
Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol (2013) 4.76
Obesity and colorectal cancer. Gut (2013) 3.29
A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol (2011) 3.18
Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med (2003) 2.99
Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program. J Endourol (2014) 2.78
Predictors of immediate continence following robot-assisted radical prostatectomy. J Endourol (2012) 2.71
No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol (2012) 2.49
Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. Eur Urol (2012) 2.45
Sedation versus no sedation in the performance of diagnostic upper gastrointestinal endoscopy: a Canadian randomized controlled cost-outcome study. Am J Gastroenterol (2004) 2.38
Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol (2007) 2.30
Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol (2013) 2.26
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol (2012) 2.22
Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. Eur Urol (2011) 2.20
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology (2013) 2.16
Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol (2012) 2.16
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol (2006) 2.15
Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int (2013) 2.12
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. BJU Int (2012) 2.10
Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol (2007) 2.09
Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria. Int J Urol (2014) 2.08
Readmissions after major urologic cancer surgery. Can J Urol (2014) 2.05
Contemporary volume-outcome relationships for percutaneous nephrolithotomy: results from the Nationwide Inpatient Sample. J Endourol (2013) 2.04
Blood transfusions in radical prostatectomy: a contemporary population-based analysis. Urology (2012) 2.03
Management of acute bleeding from a peptic ulcer. N Engl J Med (2008) 2.02
Failure to renew prescriptions for gastroprotective agents to patients on continuous nonsteroidal anti-inflammatory drugs increases rate of upper gastrointestinal injury. Clin Gastroenterol Hepatol (2013) 2.02
EUS: a meta-analysis of test performance in suspected choledocholithiasis. Gastrointest Endosc (2008) 1.85
Lower GI hemorrhage controlled with endoscopically applied TC-325 (with videos). Gastrointest Endosc (2013) 1.82
Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol (2011) 1.76
Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol (2014) 1.74
Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int (2013) 1.73
Use of the endoscopically applied hemostatic powder TC-325 in cancer-related upper GI hemorrhage: preliminary experience (with video). Gastrointest Endosc (2012) 1.73
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int (2007) 1.68
Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. BJU Int (2012) 1.64
The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence. Gastroenterology (2003) 1.62
Anastomosis during robot-assisted radical prostatectomy: randomized controlled trial comparing barbed and standard monofilament suture. Urology (2011) 1.61
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis. Eur Urol (2011) 1.57
Nasogastric aspirate predicts high-risk endoscopic lesions in patients with acute upper-GI bleeding. Gastrointest Endosc (2004) 1.57
Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2008) 1.56
Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy. J Urol (2012) 1.53
Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol (2007) 1.51
Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatments. J Endourol (2014) 1.50
Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents. Can J Gastroenterol (2002) 1.50
Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma. Int J Urol (2013) 1.50
Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int (2015) 1.47
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population. BJU Int (2013) 1.47
Standardized endoscopic reporting. J Gastroenterol Hepatol (2014) 1.46
Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis. Int J Urol (2012) 1.45
Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status. Urology (2011) 1.44
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer (2007) 1.43
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. Int J Cancer (2008) 1.43
Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer (2014) 1.41
The importance of process issues as predictors of time to endoscopy in patients with acute upper-GI bleeding using the RUGBE data. Gastrointest Endosc (2006) 1.41
Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample. World J Urol (2014) 1.41
Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc (2002) 1.40
Tablet telerounding. Urology (2012) 1.39
Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data. BJU Int (2013) 1.39
Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology (2015) 1.39
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy. Urology (2012) 1.38
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis. Prostate (2013) 1.36
Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy. Ann Neurol (2005) 1.29
Polymorphism, shared functions and convergent evolution of genes with sequences coding for polyalanine domains. Hum Mol Genet (2003) 1.28
Wireless capsule endoscopy: August 2002. Gastrointest Endosc (2002) 1.24
National trends and disparities in the use of minimally invasive adult pyeloplasty. J Urol (2012) 1.24
Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States. Value Health (2008) 1.21
Robotic ultrasound probe for tumor identification in robotic partial nephrectomy: Initial series and outcomes. Int J Urol (2012) 1.16
Nonoperative imaging techniques in suspected biliary tract obstruction. HPB (Oxford) (2006) 1.12
Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer (2007) 1.11
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol (2012) 1.10
The argon plasma coagulator: February 2002. Gastrointest Endosc (2002) 1.08
The costs of colonoscopy in a Canadian hospital using a microcosting approach. Can J Gastroenterol (2008) 1.08
Cisplatin-based chemotherapy and the risk of solid tumors in patients with testicular nonseminoma: still a matter of debate. J Clin Oncol (2014) 1.07
Statistical analysis plans in observational research. JAMA (2013) 1.07
Treatment management of small renal masses in the 21st century: a paradigm shift. Ann Surg Oncol (2012) 1.07
Non-variceal upper GI bleeding in patients already hospitalized for another condition. Am J Gastroenterol (2009) 1.06
Diagnosis and management of nonvariceal upper gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol (2012) 1.06
Incidence of priapism in emergency departments in the United States. J Urol (2013) 1.05
Re: Schroeck et al.: Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia (Urology 2013;81:1177-1183). Urology (2013) 1.05
Accuracy of administrative claims data for polypectomy. CMAJ (2011) 1.02
Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc (2012) 1.02
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int (2013) 1.00
Simple clinical predictors may obviate urgent endoscopy in selected patients with nonvariceal upper gastrointestinal tract bleeding. Arch Intern Med (2007) 1.00
Prospective randomized trial of barbed polyglyconate suture to facilitate vesico-urethral anastomosis during robot-assisted radical prostatectomy: time reduction and cost benefit. BJU Int (2012) 1.00
Trends in surgery for upper urinary tract calculi in the USA using the Nationwide Inpatient Sample: 1999-2009. BJU Int (2013) 1.00
Diagnosis and management of cholecystitis and cholangitis. Gastroenterol Clin North Am (2003) 0.99
Endoscopy reporting standards. Can J Gastroenterol (2013) 0.98
A review of integrated staging systems for renal cell carcinoma. Eur Urol (2012) 0.98
Unclassified renal cell carcinoma: an analysis of 85 cases. BJU Int (2007) 0.98
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterol (2005) 0.97
Trends in percutaneous nephrolithotomy use and outcomes in the United States. J Urol (2013) 0.97
Prostate cancer screening and incidence: a question of causality. JAMA Intern Med (2013) 0.97
The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis. Can J Gastroenterol (2008) 0.96
Effect of metabolic syndrome on pathologic features of prostate cancer. Urol Oncol (2012) 0.96
Off-clamp robot-assisted partial nephrectomy preserves renal function: a multi-institutional propensity score analysis. Eur Urol (2012) 0.96
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol (2012) 0.96
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU Int (2012) 0.96
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. J Urol (2012) 0.95